Region Six Alcohol and Drug Abuse (RESADA)

Region Six Alcohol and Drug Abuse (RESADA) is a SAMHSA-registered addiction-treatment facility in Las Animas, CO. The facility provides residential + detox programming (28–90 days of 24/7 care) without a full outpatient step-down. This page frames the questions that matter most when evaluating a specific program — the ones that separate useful candidates from marginal ones.

Care levels at Region Six Alcohol and Drug Abuse (RESADA)

On care levels: Region Six Alcohol and Drug Abuse (RESADA) operates as a residential facility with detox on-site. Patients leaving here typically transition to outpatient treatment elsewhere, which makes aftercare planning a meaningful part of the admission conversation. The critical pre-admission step is an independent clinical assessment that establishes ASAM 4e level-of-care recommendation. Admission at a facility whose offered level does not match the clinical assessment produces most misaligned-placement outcomes.

Insurance and payment

Region Six Alcohol and Drug Abuse (RESADA) accepts Medicaid — which is consequential because facilities that accept Medicaid tend to have the broadest patient populations and the most developed public-sector relationships, though reimbursement structures mean program intensity sometimes differs from commercial-focused centers. Before admission, request a written Verification of Benefits from the facility's utilization-review team. Verbal VOB is where most post-admission cost-sharing disputes originate. Written documentation settles them.

Specialty programming

The facility's documented specialty programming includes: Young adults, Adult women, Pregnant/postpartum women. Specialty designations benefit from specific follow-up: programming hours per week, credentialed staff profile, integrated assessment protocols. Dual-diagnosis as a marketing category differs from operational specialty infrastructure.

Before you call

Three pre-admission questions for Region Six Alcohol and Drug Abuse (RESADA): (1) at what ASAM 4e level are you admitting me, and what is the clinical rationale; (2) can you provide written Verification of Benefits for my specific plan; (3) what is your MAT policy for opioid use disorder — specifically, do you continue buprenorphine or methadone during residential programming. If the clinical situation involves opioid use disorder, confirm explicitly whether Region Six Alcohol and Drug Abuse (RESADA) offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.